News & Press

The Melanoma Research Foundation to Host the 2022 Florida Miles for Melanoma 5K

April 21, 2022

ESTERO, FL (April 21, 2022) – The Melanoma Research Foundation (MRF) is thrilled to announce the start of its annual Miles for Melanoma nationwide 5K program bringing together local melanoma patients, survivors, care partners and survivors. This year’s …

The MRF Applauds FDA’s Commitment to Proposed Tanning Bed Rules

April 8, 2022

The MRF is proud to join our fellow members of the National Council on Skin Cancer Prevention (NCSCP) in urging the U.S. Food and Drug Administration (FDA) to finalize proposed rules that would ban minors from using tanning beds and require that adult …

Jamie’s Story: TIL Saved My Life

March 31, 2022

Guest blog post by Jamie Goldfarb, stage 4 melanoma survivor, clinical trial participant and melanoma advocate: I was diagnosed with stage 4 melanoma in January 2011.  It was the day I was supposed to return to work from maternity leave. My son was jus …

Patient Perspective: Katie Doble’s Journey with TIL Therapy

March 31, 2022

Guest blog post by Katie Doble, ocular melanoma (OM) survivor, MRF Courage Award recipient and OM advocate: TIL therapy has given my family and me next-level hope. At 31 years old, I received my first cancer diagnosis—primary uveal melanoma, meaning it …

Recent FDA Approvals for the Melanoma Community

March 23, 2022

The Melanoma Research Foundation (MRF) is pleased to share recent significant achievements for the melanoma community. In March 2022, the U.S. Food and Drug Administration (FDA) granted Iovance Biotherapeutics, Inc. an Investigational New Drug Applicat …